221 related articles for article (PubMed ID: 35660064)
41. Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
Yokoyama H; Kanda J; Kawahara Y; Uchida N; Tanaka M; Takahashi S; Onizuka M; Noguchi Y; Ozawa Y; Katsuoka Y; Ota S; Ohta T; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Nakasone H; Morishima S
Bone Marrow Transplant; 2021 Jun; 56(6):1352-1363. PubMed ID: 33420393
[TBL] [Abstract][Full Text] [Related]
42. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
Yabe T; Matsuo K; Hirayasu K; Kashiwase K; Kawamura-Ishii S; Tanaka H; Ogawa A; Takanashi M; Satake M; Nakajima K; Tokunaga K; Inoko H; Saji H; Ogawa S; Juji T; Sasazuki T; Kodera Y; Morishima Y;
Biol Blood Marrow Transplant; 2008 Jan; 14(1):75-87. PubMed ID: 18158964
[TBL] [Abstract][Full Text] [Related]
43. Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells.
Xu Q; Xue L; An F; Xu H; Wang L; Geng L; Zhang X; Song K; Yao W; Wan X; Tong J; Liu H; Liu X; Zhu X; Zhai Z; Sun Z; Wang X
Front Immunol; 2022; 13():879030. PubMed ID: 35558072
[TBL] [Abstract][Full Text] [Related]
44. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
Kröger N; Binder T; Zabelina T; Wolschke C; Schieder H; Renges H; Ayuk F; Dahlke J; Eiermann T; Zander A
Transplantation; 2006 Oct; 82(8):1024-30. PubMed ID: 17060849
[TBL] [Abstract][Full Text] [Related]
45. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
[TBL] [Abstract][Full Text] [Related]
46. Expression of killer cell inhibitor receptors on immunocompetent cells with relation to graft-versus-host disease after hematopoietic stem cell transplantation.
Duan LN; Chen C; Huang SL; Fang JP; Wei J; Bao R; Li Y; Han HX; Li SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):625-32. PubMed ID: 14706148
[TBL] [Abstract][Full Text] [Related]
47. Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
Zhang Y; Ye C; Zhu H; Zhuang Y; Chen S; Weng Y; Ren J; Luo X; Zheng J; Zheng X; Li J; Lan L; Xie Y; Han Z; Hu J; Yang T
Front Immunol; 2022; 13():1091188. PubMed ID: 36761162
[TBL] [Abstract][Full Text] [Related]
48. Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.
Martínez-Losada C; Martín C; Gonzalez R; Manzanares B; García-Torres E; Herrera C
Front Immunol; 2017; 8():810. PubMed ID: 28751893
[TBL] [Abstract][Full Text] [Related]
49. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.
Malmberg KJ; Schaffer M; Ringdén O; Remberger M; Ljunggren HG
Mol Immunol; 2005 Feb; 42(4):531-4. PubMed ID: 15607809
[TBL] [Abstract][Full Text] [Related]
50. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
51. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.
Kanda J; Ichinohe T; Kato S; Uchida N; Terakura S; Fukuda T; Hidaka M; Ueda Y; Kondo T; Taniguchi S; Takahashi S; Nagamura-Inoue T; Tanaka J; Atsuta Y; Miyamura K; Kanda Y;
Leukemia; 2013 Feb; 27(2):286-94. PubMed ID: 22806066
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.
Ishida H; Kato M; Kawahara Y; Ishimaru S; Najima Y; Kako S; Sato M; Hiwatari M; Noguchi M; Kato K; Koh K; Okada K; Iwasaki F; Kobayashi R; Igarashi S; Saito S; Takahashi Y; Sato A; Tanaka J; Hashii Y; Atsuta Y; Sakaguchi H; Imamura T
Hematol Oncol; 2022 Aug; 40(3):457-468. PubMed ID: 35212019
[TBL] [Abstract][Full Text] [Related]
53. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
[TBL] [Abstract][Full Text] [Related]
54. Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission.
Tanaka J; Morishima Y; Takahashi Y; Yabe T; Oba K; Takahashi S; Taniguchi S; Ogawa H; Onishi Y; Miyamura K; Kanamori H; Aotsuka N; Kato K; Kato S; Atsuta Y; Kanda Y
Blood Cancer J; 2013 Nov; 3(11):e164. PubMed ID: 24292416
[TBL] [Abstract][Full Text] [Related]
55. [The prognostic analysis of KIR ligand mismatch in HLA-mismatched hematopoietic stem cell transplantation].
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):316-20. PubMed ID: 18844069
[TBL] [Abstract][Full Text] [Related]
56. Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.
Tamaki M; Akahoshi Y; Okada Y; Uchida N; Tanaka M; Doki N; Sawa M; Maruyama Y; Ueda Y; Miyakoshi S; Katayama Y; Kawakita T; Kimura T; Onizuka M; Fukuda T; Atsuta Y; Yanagisawa R; Yakushijin K; Kanda J; Nakasone H
Cytotherapy; 2023 Nov; 25(11):1220-1228. PubMed ID: 37341665
[TBL] [Abstract][Full Text] [Related]
57. Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.
Bachanova V; Weisdorf DJ; Wang T; Marsh SGE; Cereb N; Haagenson MD; Spellman SR; Lee SJ; Guethlein LA; Parham P; Miller JS; Cooley SA
Biol Blood Marrow Transplant; 2019 May; 25(5):949-954. PubMed ID: 30594542
[TBL] [Abstract][Full Text] [Related]
58. [Comparison of umbilical cord blood transplantation and hematopoietic stem cell transplantation from HLA-matched sibling donors in the treatment of myelodysplastic syndrome-EB or acute myeloid leukemia with myelodysplasia-related changes].
Zhu J; Tang BL; Song KD; Zhang XH; Zhu XY; Yao W; Wan X; Liu HL; Sun ZM
Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):294-300. PubMed ID: 31104440
[No Abstract] [Full Text] [Related]
59. Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.
Kanda J; Umeda K; Kato K; Murata M; Sugita J; Adachi S; Koh K; Noguchi M; Goto H; Yoshida N; Sato M; Koga Y; Hori T; Cho Y; Ogawa A; Inoue M; Hashii Y; Atsuta Y; Teshima T;
Bone Marrow Transplant; 2020 Jul; 55(7):1430-1437. PubMed ID: 32161321
[TBL] [Abstract][Full Text] [Related]
60. Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.
Shimoni A; Vago L; Bernardi M; Yerushalmi R; Peccatori J; Greco R; Shem-Tov N; Lo Russo A; Danylesko I; Apel A; Bonini C; Lupo Stanghellini MT; Nagler A; Ciceri F
Am J Hematol; 2017 Oct; 92(10):1011-1019. PubMed ID: 28631269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
